Zhai Shumei
Associate Professor
近几年主要致力于研究功能化纳米材料的免疫效应及其在生物医学领域的应用。目前，已经主持或参与完成包括国家自然基金青年基金 、国家自然基金面上项目、国家973子课题、国家重点研发计划课题、国家自然科学基金重点项目等多项致力于研究纳米材料生物效应的课题。相关研究成果已经在Cell Death and Disease.、Cancer Letters.、Plos One、Biomaterials、ACS Nano等杂志上发表。参与申请发明专利15项，其中8项已授权。 2021年度拟招收1名硕士研究生。 主持或参加科研项目（课题）... More+
Paper Publications
-
[21] 孙海南. The Rational Design and Biological Mechanisms of Nanoradiosensitizers. Nanomaterials , 2020.
-
[22] 孙海南. Gold Nanoparticle-Induced Cell Death and Potential Applications in Nanomedicine. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , 2018.
-
[23] jiangcuijuan , baixue , Zhai Shumei and 孙海南. Cytotoxicity-Related Bioeffects Induced by Nanoparticles: The Role of Surface Chemistry. Frontiers in Bioengineering and Biotechnology, 7, 2019.
-
[24] Zhai Shumei. 生物学方法在环境内分泌干扰物检测及评价中的应用. 《环境化学》, 27, 684, 2008.
-
[25] Zhai Shumei and yanbing. Tumor cellular proteasome inhibition and growth suppression by 8-hydroxyquinoline and clioquinol .... J Bio Inorg Chem, 15, 259, 2010.
-
[26] jiangcuijuan , yanbing , Zhai Shumei and 贾建博. Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer Immunother.... FRONTIERS IN ONCOLOGY, 8, 2018.
-
[27] wanglei , Zhai Shumei , jiangwei and 赵海燕. Ultrasensitive and Accurate Assay of Human Methyltransferase Activity at the Single-Cell Level Ba.... ACS Applied Materials & Interfaces, 9, 29554, 2017.
-
[28] Zhai Shumei , yanbing and 贾建博. Susceptibility of Overweight Mice to Liver Injury as a Result of the ZnO Nanoparticle-Enhanced Li.... Environmental Science & Technology, 51, 1775, 2017.
-
[29] yanbing , Zhai Shumei and Zhang Bin. Experimental Modulation and Computational Model of Nano-Hydrophobicity.. Biomaterials, 2015.
-
[30] Zhai Shumei and yanbing. A Novel Dithiocarbamate Analogue with Potentially Decreased ALDH Inhibition has Copper-Dependent .... Cancer letters, 300, 87, 2011.
-
[31] Zhai Shumei and zhangjuren. Overexpression of a Zea mays phospholipase C1 gene enhances drought tolerance in tobacco in part .... Plant Cell Tissue Organ Culture, 115, 2013.
-
[32] zhangqiu , yanbing and Zhai Shumei. Anti-tumor selectivity of a novel Tubulin and HSP90 dual-targeting inhibitor in non-small cell lu.... Biochem Pharmacol, 86, 351, 2013.
-
[33] Zhai Shumei , zhangjuren and yangaifang. overexpression of the phosphatidylinositol synthase gene from Zea mays in tobacco plants alters t.... planta, 2012.
-
[34] yanbing and Zhai Shumei. Enhanced cancer cell killing by a targeting gold nanoconstruct with doxorubicin payload under X-r.... RSC advances, 3, 21596, 2013.
-
[35] Zhai Shumei and yanbing. Reducing Both Pgp Overexpression and Drug Efflux with Anti-Cancer Gold-Paclitaxel Nanoconjugates..... Plos one, 2016.
-
[36] Zhai Shumei and yanbing. Recent Patents on Treatment of Severe Acute Respiratory Syndrome (SARS). Recent patents on Anti-Infective Drug Discovery, 10, 1, 2007.
-
[37] yanbing , zhangqiu and Zhai Shumei. From fighting depression to conquering tumors: a novel tricyclic thiazepine compound as a tubulin.... 《Cell Death and Disease》, 2016.
-
[38] Zhai Shumei , yanbing and Zhang Bin. Induction of Size-Dependent Breakdown of Blood-Milk Barrier in Lactating Mice by TiO2 Nanoparticl.... Plos one, 2015.
-
[39] Zhai Shumei and yanbing. Novel Natural Product- and Privileged Scaffold-Based Tubulin Inhibitors Targeting the Colchicine .... Molecule, 2016.
-
[40] zhangqiu , yanbing , Zhai Shumei and jiangcuijuan. P-glycoprotein-evading anti-tumor activity of a novel tubulin and HSP90 dual inhibitor in a. Journal of Pharmacological Sciences, 126, 66, 2014.